TFIFF Stock UPDATES Transforce Inc Fund (TFIFF) 25.3000 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 10, 2014 at 7:54 PM

Transforce Inc Fund (TFIFF) 25.3000 $TFIFF

TransForce commences friendly, Board-approved take-over bid to acquire Contrans Group Inc.
CNW Group - Tue Aug 12, 12:20PM CDT
All amounts expressed in CAD$

TransForce signs agreement to acquire Contrans Group Inc.
CNW Group - Thu Jul 24, 5:42PM CDT
All amounts expressed in CAD$

TransForce Announces 2014 Second Quarter Results
CNW Group - Thu Jul 24, 4:05PM CDT
TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, today announced its results for the second quarter ended June 30, 2014.

/R E P E A T -- TransForce Inc. will Hold a Conference Call to Discuss its Second Quarter Results/
CNW Group - Thu Jul 24, 7:30AM CDT
TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, today announced that it will issue its financial results for the second quarter ended June 30, 2014 via news release on Thursday, July 24, 2014 after market closes.

TransForce Inc. will Hold a Conference Call to Discuss its Second Quarter Results
CNW Group - Fri Jul 04, 7:30AM CDT
TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, today announced that it will issue its financial results for the second quarter ended June 30, 2014 via news release on Thursday, July 24, 2014 after market closes.

TransForce concludes acquisition of Transport America, Inc.
CNW Group - Thu Jul 03, 4:05PM CDT
TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, today announced that a wholly-owned subsidiary of TransForce has completed the acquisition of the entire share capital of Transport America, Inc. ("Transport America"

, an important provider of truckload ("TL"

carriage and logistics services. Transport America was a portfolio company of Minneapolis-based Goldner Hawn Johnson & Morrison Incorporated.

TransForce Declares Quarterly Dividend
CNW Group - Mon Jun 16, 7:30AM CDT
The Board of Directors of TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, declared a quarterly dividend of $0.145 per outstanding common share of its capital payable on July 15, 2014 to shareholders of record at the close of business on June 30, 2014. This dividend is designated to be an eligible dividend pursuant to subsection 89(14) of the Income Tax Act (Canada) and any applicable provincial legislation pertaining to eligible dividends.

TransForce Completes Acquisition of Vitran
CNW Group - Wed Mar 26, 4:50PM CDT
TransForce Inc. ("TransForce"

(TSX: TFI, OTCQX:TFIFF), a North American leader in the transportation and logistics industry, and Vitran Corporation Inc. ("Vitran"

(NASDAQ: VTNC) (TSX: VTN), a premier Canadian less-than-truckload ("LTL"

transportation firm, are pleased to announce that the previously announced acquisition of Vitran by TransForce by way of plan of arrangement (the "Arrangement"

has been completed. Under the Arrangement, 2400520 Ontario Inc. (the "Purchaser"

, an indirect wholly-owned subsidiary of TransForce, acquired all of the issued and outstanding common shares of Vitran, other than common shares of Vitran held by the Purchaser and any affiliate of the Purchaser, for consideration of US$6.50 in cash per share.

TransForce declares quarterly dividend
CNW Group - Tue Mar 18, 7:30AM CDT
The Board of Directors of TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, declared a quarterly dividend of $0.145 per outstanding common share of its capital payable on April 15, 2014 to shareholders of record at the close of business on March 31, 2014. This dividend is designated to be an eligible dividend pursuant to subsection 89(14) of the Income Tax Act (Canada) and any applicable provincial legislation pertaining to eligible dividends.

OTC Markets Group Reports 2013 Trading Statistics and Highlights
PR Newswire - Wed Jan 29, 9:17AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced its trading statistics and highlights for 2013 as well as its plans for 2014.

TransForce shares begin trading on OTCQX Market
CNW Group - Thu Sep 12, 8:30AM CDT
TransForce Inc. (TSX: TFI) (OTCQX: TFIFF), a North American leader in the transportation and logistics industry, announces that its common shares began trading today in the United States on OTCQX International Premier, a segment of the OTCQX marketplace, under the symbol "TFIFF." Operated by OTC Markets Group Inc. (OTCQX: OTCM), OTCQX International Premier is reserved for world-leading non-U.S. companies that are listed on a qualified international exchange, undergo management reviews and provide their home country disclosure to U.S. investors.

TransForce Inc. Begins Trading on OTCQX®
PR Newswire - Thu Sep 12, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that TransForce Inc. (OTCQX: TFIFF; TSX: TFI), a North American leader in the transportation and logistics industry, has been approved to trade on OTCQX®, the best marketplace with qualified companies.

TransForce acquires Superior Driver Source of Tennessee and the Carolinas
PR Newswire - Wed Jan 30, 10:36AM CST
TransForce, Inc., an industry leader in providing professional commercial truck drivers on a temporary, contingent or contract basis and transportation compliance services, announced that it has acquired Superior Driver Source, Inc. and Superior Driver Source of the Carolinas (Superior). Superior provides commercial truck drivers in the southeastern U.S. with operations in Tennessee, North Carolina, Kentucky, Georgia, Mississippi and South Carolina. Superior's senior management has joined TransForce's leadership team and will assume key regional management roles, ensuring seamless customer service. Terms of the transaction were not disclosed.

CPRX, GVI, PRTS, LAG, TFI, SDBT Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Jan 29, 4:50AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX), iShares Barclays Intermediate Govt/Credit Bd Fd (NYSE:GVI), US Auto Parts Network Inc (NASDAQ

RTS), SPDR Barclays Capital Aggregate Bond ETF (NYSE:LAG), TransForce Inc (NYSE:TFI), SoundBite Communications Inc (NASDAQ:SDBT) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

TransForce Inc. Acquires Shares of Vitran Corporation Inc.
CNW Group - Thu Jan 24, 5:00PM CST
TransForce Inc. (TSX: TFI), a North American leader in the transportation and logistics industry, announces that it has indirectly acquired ownership of, and control and direction over, an aggregate of 1,763,478 common shares of Vitran Corporation Inc. (NASDAQ: VTNC, TSX: VTN), representing, to TransForce's knowledge, 10.75% of the issued and outstanding common shares of Vitran. TransForce acquired the shares during the period from December 17, 2012 to January 24, 2013.

TransForce Announces Acquisition of Velocity Express
CNW Group - Thu Jan 17, 8:07AM CST
Acquisition further enhances TransForce's presence in the same-day North American package and courier market

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...